DK0977586T3 - Kombinationer af antigen og mucosa-bindende bestanddel til induktion af specifik immunologisk tolerans - Google Patents

Kombinationer af antigen og mucosa-bindende bestanddel til induktion af specifik immunologisk tolerans

Info

Publication number
DK0977586T3
DK0977586T3 DK98918742T DK98918742T DK0977586T3 DK 0977586 T3 DK0977586 T3 DK 0977586T3 DK 98918742 T DK98918742 T DK 98918742T DK 98918742 T DK98918742 T DK 98918742T DK 0977586 T3 DK0977586 T3 DK 0977586T3
Authority
DK
Denmark
Prior art keywords
combinations
antigen
tolerance
binding component
mucosa
Prior art date
Application number
DK98918742T
Other languages
Danish (da)
English (en)
Inventor
Jacob Sten Petersen
Original Assignee
Pedersen Jacob Sten
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pedersen Jacob Sten filed Critical Pedersen Jacob Sten
Application granted granted Critical
Publication of DK0977586T3 publication Critical patent/DK0977586T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55544—Bacterial toxins
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/81—Drug, bio-affecting and body treating compositions involving autoimmunity, allergy, immediate hypersensitivity, delayed hypersensitivity, immunosuppression, immunotolerance, or anergy
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/868—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof involving autoimmunity, allergy, immediate hypersensitivity, delayed hypersensitivity, immunosuppression, or immunotolerance

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK98918742T 1997-04-23 1998-04-23 Kombinationer af antigen og mucosa-bindende bestanddel til induktion af specifik immunologisk tolerans DK0977586T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US4418297P 1997-04-23 1997-04-23
US4418497P 1997-04-23 1997-04-23

Publications (1)

Publication Number Publication Date
DK0977586T3 true DK0977586T3 (da) 2005-12-05

Family

ID=26721263

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98918742T DK0977586T3 (da) 1997-04-23 1998-04-23 Kombinationer af antigen og mucosa-bindende bestanddel til induktion af specifik immunologisk tolerans

Country Status (8)

Country Link
US (1) US7097845B2 (fr)
EP (1) EP0977586B1 (fr)
JP (1) JP2001523249A (fr)
AT (1) ATE299711T1 (fr)
AU (1) AU7161098A (fr)
DE (1) DE69830900T2 (fr)
DK (1) DK0977586T3 (fr)
WO (1) WO1998047529A1 (fr)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9800487D0 (en) * 1998-01-09 1998-03-04 Oratol Limited Therapies
AU7404800A (en) * 1999-09-30 2001-04-30 Novo Nordisk A/S A method for preparing conjugates between an antigen and mucosal binding component
US7807463B2 (en) 2000-01-25 2010-10-05 The Board Of Regents Of The University Of Nebraska Pre-transplant accommodated organs resistant to anti-donor immunity
US7897575B2 (en) * 2000-05-24 2011-03-01 The United States Of America As Represented By The Department Of Health And Human Services Treatment and prevention of vascular dementia
WO2002093998A2 (fr) * 2001-05-23 2002-11-28 Duotol Ab Suppression de reactions allergiques par administration intradermique d'allergenes conjugues avec des sous unites de toxine ou des fragments de celle-ci
WO2005012347A2 (fr) 2003-08-05 2005-02-10 Novo Nordisk A/S Nouveaux derives de l'insuline
EP2505593A1 (fr) 2005-12-28 2012-10-03 Novo Nordisk A/S Compositions renfermant de l'insuline acylée et du zinc et procédé de fabrication des dites compositions
CN101677947B (zh) 2007-06-13 2013-07-17 诺沃-诺迪斯克有限公司 包含胰岛素衍生物的药物制剂
US9603904B2 (en) 2008-10-30 2017-03-28 Novo Nordisk A/S Treating diabetes melitus using insulin injections with less than daily injection frequency
BR112012028766A2 (pt) * 2010-05-10 2017-06-13 Novo Nordisk As processo para a preparação de complexos de insulina e zinco
JP6049625B2 (ja) 2010-10-27 2016-12-21 ノヴォ ノルディスク アー／エス 様々な注射間隔を用いて施されるインスリン注射を使用する、真性糖尿病の治療
US10137172B2 (en) 2013-04-30 2018-11-27 Novo Nordisk A/S Administration regime
US10335464B1 (en) 2018-06-26 2019-07-02 Novo Nordisk A/S Device for titrating basal insulin
WO2022177890A1 (fr) * 2021-02-16 2022-08-25 Applied Molecular Transport Inc. Compositions orales solides contenant du zinc

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4666837A (en) 1982-05-24 1987-05-19 Smithkline-Rit DNA sequences, recombinant DNA molecules and processes for producing the A and B subunits of cholera toxin and preparations containing so-obtained subunit or subunits
DK97986A (da) * 1985-03-08 1986-09-09 Takeda Chemical Industries Ltd Middel til inhibering af fordoejelse af sakkarid
US5399347A (en) 1987-06-24 1995-03-21 Autoimmune, Inc. Method of treating rheumatoid arthritis with type II collagen
EP0666080B1 (fr) 1987-06-24 2004-01-21 Brigham & Women's Hospital Traitement de maladies auto-immunitaires par administration orale d'auto-antigènes
JPH02235823A (ja) 1989-03-09 1990-09-18 Watanabe Mitsuko 抗アレルギー剤
JP2891485B2 (ja) 1989-09-25 1999-05-17 科学技術振興事業団 移植拒絶反応抑制剤
HUT61487A (en) 1989-12-20 1993-01-28 Brigham & Womens Hospital Process for producing aerosol pharmaceutical composition comprising autoantigens
EP0594607B1 (fr) 1990-03-02 1997-08-27 Autoimmune, Inc. Amelioration de la regulation reductrice de maladies autoimmunes par administration orale ou enterale d'autoantigenes
CA2050425A1 (fr) 1990-09-03 1992-03-04 Yoshiaki Uda Composition pharmaceutique et son utilisation avec du mucus
JP3198390B2 (ja) * 1990-09-03 2001-08-13 武田薬品工業株式会社 経粘膜用製剤
IL99864A (en) 1990-10-31 2000-11-21 Autoimmune Inc Compositions for suppressing transplant rejection in mammals which contain tissue donor derived MHC antigens
KR950700082A (ko) 1992-02-28 1995-01-16 로버트 씨. 비숍 바이스탠더(bystander)에 의한 자가면역질환을 처치하는 방법
US5453272A (en) 1992-10-02 1995-09-26 Alberta Research Council Lectin derived carbohydrate binding-peptide
JP3109328B2 (ja) 1993-05-19 2000-11-13 ウシオ電機株式会社 加熱定着装置
CA2164326A1 (fr) 1993-06-02 1994-12-08 Wayne Robert Thomas Peptides caches, utiles pour induire la tolerance immunitaire
US5681571A (en) 1993-10-08 1997-10-28 Duotol Ab Immunological tolerance-inducing agent
JP2847695B2 (ja) * 1994-05-11 1999-01-20 田辺製薬株式会社 血糖降下剤
JP2847696B2 (ja) * 1994-05-11 1999-01-20 田辺製薬株式会社 プロピオフェノン誘導体及びその製法
IL111866A (en) 1994-12-04 2005-03-20 Yeda Res & Dev Pharmaceutical compositions comprising the b-oligomer of pertussis toxin
WO1996021458A1 (fr) 1995-01-10 1996-07-18 Fibrogen, Inc. Methodes et formulations a base de collagene pour le traitement de maladies d'origine immunologique
WO1996039176A1 (fr) 1995-06-05 1996-12-12 Brigham & Women's Hospital Utilisation de la tolerance orale pour supprimer les reponses immunitaires de th1 et de th2 et pour supprimer la production d'anticorps
GB9513733D0 (en) 1995-07-05 1995-09-06 Univ Bristol Therapeutic agents

Also Published As

Publication number Publication date
US20020119159A1 (en) 2002-08-29
AU7161098A (en) 1998-11-13
DE69830900T2 (de) 2006-05-24
ATE299711T1 (de) 2005-08-15
US7097845B2 (en) 2006-08-29
WO1998047529A1 (fr) 1998-10-29
DE69830900D1 (de) 2005-08-25
EP0977586B1 (fr) 2005-07-20
EP0977586A1 (fr) 2000-02-09
JP2001523249A (ja) 2001-11-20

Similar Documents

Publication Publication Date Title
DK0977586T3 (da) Kombinationer af antigen og mucosa-bindende bestanddel til induktion af specifik immunologisk tolerans
NO934284D0 (no) Farmas!ytisk preparat inneholdende et definert lipidsystem
EE9900481A (et) Väikesed molekulid, mida kasutatakse põletikuliste haiguste raviks
ATE463505T1 (de) Toll-ähnlichen-rezeptor-5-liganden und verwendungsverfahren
NO20016007L (no) Rekombinant anti-CD40-antistoff og anvendelser derav
DK0865297T3 (da) Vaccinesammensætninger til intranasal administration omfattende chitosan og anvendelsen deraf
DK1093819T3 (da) Forbindelse og præparat til tilförsel af aktive midler
FI972945A0 (fi) Antigeenien antamiseen soveltuvia koostumuksia
DE69840603D1 (de) Alpha-ketoamidhaltige multikatalytische protease inhibitoren
IL111134A (en) Immunological tolerance-inducing composition comprising a mucosa-binding molecule linked to a specific self-antigen/tolerogen
NL300152I1 (nl) Preparaat dat een tramadolverbinding en aceetaminofen bevat.
ATE356608T1 (de) Behandlung der multiplen sklerose durch einnahme von copolymer-1
NO995718L (no) Urte-ekstraktsammensetning og metode med innum-"boosting"- evne
DK0588578T3 (da) Immunogener
WO1998046270A3 (fr) Molecules presentant une pluralite de groupes fonctionnels actifs
MX9601378A (es) Adyuvante de quillaja saponaria y formulacion de vacuna que contiene la misma.
DE69528074D1 (de) Chitosan induzierte verstärkung
NO996274L (no) CD154-blokkering for terapeutisk protein-inhibitorsyndrom
ID18542A (id) Rangkaian-rangkaian asam nukleat dan asam amino yang berhubungan dengan helicobacter pilory dan komposisi-komposisi vaksin dari padanya
DK0584247T3 (da) Sammensætninger til behandling af kronisk træthedssyndrom
WO2001017537A3 (fr) Techniques et compositions permettant de reduire la reponse immunitaire
DK1183037T3 (da) Sammensætninger til modulering af immunrespons og til behandling af inflammatoriske sygdomme
NO982463L (no) Anvendelse av en kombinasjon av pentoksyfyllin og type I-interferoner til behandling av multippel sklerose
DK0831881T3 (da) CETP til forøgelse af HDL-cholesterolniveau
BR9714189A (pt) N-(piridinilamino) isoindolinas e compostos relacionados